Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk Dombrowski

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The International Journal on Drug Policy|February 5, 2017
Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto RicoMelissa Welch-Lazoritz, Patrick Habecker, Kirk Dombrowski, et al.
Plos One|November 30, 2018
Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experimentBilal Khan, Ian Duncan, Mohamad Saad, et al.
Systematic Reviews|March 28, 2014
Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysisHolly Hagan, Joshua Neurer, Ashly E Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2019
Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use PopulationElizabeth R Stevens, Kimberly A Nucifora, Holly Hagan, et al.
AIDS and Behavior|April 9, 2013
Theory, measurement and hard times: some issues for HIV/AIDS researchSamuel R Friedman, Milagros Sandoval, Pedro Mateu-Gelabert, et al.
Frontiers in Psychiatry|October 20, 2022
Employing Respondent Driven Sampling (RDS) to recruit people who inject drugs (PWID) and other hard-to-reach populations during COVID-19: Lessons learnedRoberto Abadie, Patrick Habecker, Kimberly Gocchi Carrasco, et al.
Plos One|November 2, 2017
Bi-cultural dynamics for risk and protective factors for cardiometabolic health in an Alaska Native (Yup'ik) populationJacques Philip, Tove K Ryman, Scarlett E Hopkins, et al.
Applied Neuropsychology. Adult|August 24, 2024
Cognitive Intraindividual variability in injection drug use among Hispanic residents of Puerto RicoKathy S Chiou, Jeremy A Feiger, Rachael L Snyder, et al.
Frontiers in Microbiology|December 19, 2024
Gut microbiota profiling in injection drug users with and without HIV-1 infection in Puerto RicoNirosh Aluthge, Seidu Adams, Carmen A Davila, et al.
Journal of Leukocyte Biology|April 12, 2023
Immune profiling in Puerto Rican injection drug users with and without HIV-1 infectionSydney J Bennett, Carmen Ana Davila, Zahiraliz Reyes, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The International Journal on Drug Policy|February 5, 2017
Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto RicoMelissa Welch-Lazoritz, Patrick Habecker, Kirk Dombrowski, et al.
Plos One|November 30, 2018
Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experimentBilal Khan, Ian Duncan, Mohamad Saad, et al.
Systematic Reviews|March 28, 2014
Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysisHolly Hagan, Joshua Neurer, Ashly E Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2019
Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use PopulationElizabeth R Stevens, Kimberly A Nucifora, Holly Hagan, et al.
AIDS and Behavior|April 9, 2013
Theory, measurement and hard times: some issues for HIV/AIDS researchSamuel R Friedman, Milagros Sandoval, Pedro Mateu-Gelabert, et al.
Frontiers in Psychiatry|October 20, 2022
Employing Respondent Driven Sampling (RDS) to recruit people who inject drugs (PWID) and other hard-to-reach populations during COVID-19: Lessons learnedRoberto Abadie, Patrick Habecker, Kimberly Gocchi Carrasco, et al.
Plos One|November 2, 2017
Bi-cultural dynamics for risk and protective factors for cardiometabolic health in an Alaska Native (Yup'ik) populationJacques Philip, Tove K Ryman, Scarlett E Hopkins, et al.
Applied Neuropsychology. Adult|August 24, 2024
Cognitive Intraindividual variability in injection drug use among Hispanic residents of Puerto RicoKathy S Chiou, Jeremy A Feiger, Rachael L Snyder, et al.
Frontiers in Microbiology|December 19, 2024
Gut microbiota profiling in injection drug users with and without HIV-1 infection in Puerto RicoNirosh Aluthge, Seidu Adams, Carmen A Davila, et al.
Journal of Leukocyte Biology|April 12, 2023
Immune profiling in Puerto Rican injection drug users with and without HIV-1 infectionSydney J Bennett, Carmen Ana Davila, Zahiraliz Reyes, et al.
Pageof 5